Profound Medical Corp.

(PRN:PUR)

By |

Profile

Profound Medical Corp is a biotechnology company. It develops a treatment to ablate the prostate gland in prostate cancer patients. It commercializes a novel technology TULSA-PRO, which combines real-time magnetic resonance imaging with transurethral. It also commercializes Sonalleve MR-HIFU an innovative therapeutic platform that combines real-time MR imaging and thermometry with thermal ultrasound to enable precise and incision-free ablation of diseased tissue.

Contact Information

Website: www.profoundmedical.com
Main Phone: +1 647 476-1350
Address: 2400 Skymark Avenue
Address 2: Unit 6
State: ON
City / Town: Mississauga
Country: CAN
Postal Code: L4W 5K5

Issuer Information

Exchange: TSX
CEO: Arun Menawat
Employees: 64
NAICS: Medical Laboratories(621511)
$ 0.57 $ 0. (0.00%)
Last Price 0.57 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.57
Last Trade Volume 0 52 Wk Hi 1.20 52 Wk Low 0.57
Market Cap 61.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 108,054,939.00 EPS (TTM) -0.22 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3.1 3.1 3.1 3.1
Low Target Price Estimate 1.5 1.5 1.5 1.5
Mean Target Price Estimate 2.53 2.53 2.53 2.53
Standard Deviation 0.9 0.9 0.9 0.9
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.43 1.43 1.43 1.43